Healthcare providers, insurance companies, and drug makers should make information about quality and prices available to the public, according to the latest New York-based Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders Survey.
The survey of leaders in healthcare and health policy focused on transparency in health care quality and pricing. Three-quarters of respondents believe increased transparency of quality and price information is essential to improving the performance of the U.S. healthcare system.
In addition to public reporting on provider quality and prices, 88 percent of respondents support reporting of drug prices charged to major purchasers and 82 percent support the reporting of medical loss ratios. A similar share of respondents thinks that more widespread reporting of information could stimulate providers to improve their performance through quality improvement activities.